Treatment Response to Idiopathic Retroperitoneal Fibrosis-associated Hydronephrosis With a Focus on IgG4/IgG3 Serum Concentration Ratio.
Choi SJ, Oh JS, Hong S, Lee CK, Yoo B, Hong B, Kim YG.
J Rheum Dis. 2021 Jan 1;28(1):38-44. doi: 10.4078/jrd.2021.28.1.38.
PMID:37476393
The Baseline Serum IgG4/IgG3 Ratio Might be a Suitable Marker for Predicting Favorable Treatment Response in Patients With Idiopathic Retroperitoneal Fibrosis-associated Hydronephrosis.